Elena Becker-Barroso is a Spanish molecular biologist and the editor in chief of Lancet Neurology.
Becker-Barroso obtained a bachelor's degree in life sciences from the University of Exeter in 1997 [1] and has a PhD in molecular biology from the University of Salamanca. [2]
She undertook postdoctoral research at the Skirball Institute of Biomolecular Medicine at New York University, [3] and has a diploma in science communication from Birkbeck University. [1]
Becker-Barroso joined in the editorial department of Lancet Neurology in 2005 [1] before becoming the editor-in-chief of in 2012. [3]
Becker-Barroso has an honorary degree from the University of Exeter. [1]
José Manuel Durão Barroso is a Portuguese politician and university teacher, currently serving as non-executive chairman of Goldman Sachs International. He previously served as the 11th president of the European Commission and the 115th prime minister of Portugal.
The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind. It is also the world's highest-impact academic journal. It was founded in England in 1823.
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Neuroepidemiology is a science of incidence, prevalence, risk factors, natural history and prognosis of neurological disorders, as well as of experimental neuroepidemiology, which is research based on clinical trials of effectiveness or efficacy of various interventions in neurological disorders.
Jean Aicardi was a French pediatric neurologist and epileptologist. He was known as one of the most distinguished and respected neuropediatricians of his time. He, along with Alexis Arzimanoglou, created the journal Epileptic Disorders in 1999.
Morton Owen Schapiro is an American economist who served as the 16th president of Northwestern University from 2009 to 2022.
NeuroQuantology is a monthly peer-reviewed interdisciplinary scientific journal meant to cover the intersection of neuroscience and quantum mechanics. It was established in April 2003 and its subject matter almost immediately dismissed in The Lancet Neurology as "wild invention" and "claptrap". According to the Journal Citation Reports, the journal had a 2017 impact factor of 0.453, ranking it 253rd out of 261 journals in the category "Neuroscience". However, the journal has been delisted since the 2019 edition. The journal describes itself as focusing primarily on original reports of experimental and theoretical research. It also publishes literature reviews, methodological articles, empirical findings, book reviews, news, comments, letters to the editor, and abstracts. The founding editor-in-chief is Sultan Tarlacı, who was succeeded by Riyaz Ahmed abdul Khan.
Ole Petter Ottersen is a Norwegian physician and neuroscientist. He serves as the Rector of Karolinska Institute in Sweden, and took office in August 2017. Ottersen has been professor of medicine at the University of Oslo since 1992 and served as the university's directly elected Rector from 2009 to 2017.
Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.
Mark S. Gold is an American physician, professor, author, and researcher on the effects of opioids, cocaine, tobacco, and other drugs as well as food on the brain and behavior. He is married to Janice Finn Gold.
Richard William Barker is the Founder of New Medicine Partners and Founding Director of the University of Oxford — University College of London Centre for the Advancement of Sustainable Medical Innovation (CASMI).
Martin Charles Raff is a Canadian/British biologist and researcher who is an Emeritus Professor at the MRC Laboratory for Molecular Cell Biology (LMCB) at University College London (UCL). His research has been in immunology, cell biology, and developmental neurobiology.
James Rutka is a Canadian neurosurgeon from Toronto, Canada. Rutka served as RS McLaughlin Professor and Chair of the Department of Surgery in the Faculty of Medicine at the University of Toronto from 2011 – 2022. He subspecializes in pediatric neurosurgery at The Hospital for Sick Children (SickKids), and is a Senior Scientist in the Research Institute at SickKids. His main clinical interests include the neurosurgical treatment of children with brain tumours and epilepsy. His research interests lie in the molecular biology of human brain tumours – specifically in the determination of the mechanisms by which brain tumours grow and invade. He is the Director of the Arthur and Sonia Labatt Brain Tumour Research Centre at SickKids, and Editor-in-Chief of the Journal of Neurosurgery.
Thomas Solomon is Professor of Neurology, director of the Institute of Infection and Global Health at the University of Liverpool, and director of the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections. In 2021 he was elected Fellow of the UK Academy of Medical Sciences.
Stephen George Waxman is an American neurologist and neuroscientist. He served as Chairman of the Department of Neurology at Yale School of Medicine, and Neurologist-in-Chief at Yale-New Haven Hospital from 1986 until 2009. As of 2018, he is the Bridget Flaherty Professor of Neurology, Neurobiology, and Pharmacology at Yale University. He founded the Yale University Neuroscience & Regeneration Research Center in 1988 and is its Director. He previously held faculty positions at Harvard Medical School, MIT, and Stanford Medical School. He is also visiting professor at University College London. He is the editor-in-chief of The Neuroscientist and Neuroscience Letters.
Annalisa Pastore is a Professor of Chemistry and Molecular Biology at King's College London. In 2018 she was appointed full professor at the Scuola Normale Superiore di Pisa. In 2022, she was appointed director of research for life sciences, chemistry and soft matter science at European Synchrotron Radiation Facility. She resigned in Frebruary 2023.
Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an Adjunct Professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.
Raad Shakir CBE is Professor of Neurology at Imperial College London and a Consultant Neurologist at Charing Cross Hospital.
Michael Brainin is an Austrian neurologist and emeritus professor at the Danube University Krems. He is widely known as a pioneer in stroke research and prevention as well as a leading figure in the development of stroke units. Brainin was president of the Austrian Stroke Society, the European Stroke Organisation and the World Stroke Organization.
Ava Easton is a health scientist and researcher who specialises in encephalitis, acquired brain injury and narrative medicine, and is considered a world expert in her field of Encephalitis patient outcomes and quality of life. She is the current Chief Executive of The Encephalitis Society, a non-profit organisation which provides support and resources for those affected by the neurological disease of Encephalitis, and collaborates with various organisations on research into the disease.